Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus - Single center experience

Journal of Interventional Cardiac Electrophysiology

Volumn 17, Issue 1, 2006, Pages 41-46

  Tang, Ri Bo ^a   Dong, Jian Zeng ^a   Liu, Xing Peng ^a   Fang, Dong Ping ^a   Long, De Yong ^a   Liu, Xiao Hui ^a   Yu, Rong Hui ^a   Hu, Fu Li ^a   Lu, Chun Shan ^a   Hao, Peng ^a   Kalifa, Jérôme ^b   Ma, Chang Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Ablation; Atrial fibrillation; Complication; Diabetes mellitus

Indexed keywords

ADULT; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HEMATOMA; HUMAN; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; STROKE; TREATMENT RESPONSE;

ATRIAL FIBRILLATION; CATHETER ABLATION; CHINA; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 33847139430     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-006-9049-x     Document Type: Article

References (32)

1. Akazawa, Y., & Akazawa, S. (2002). Diabetes in Japan and the global burden of diabetes. Nippon Rinsho, 60(Suppl 8), 93-102.
2. King, H., Aubert, R. E., & Herman, W. H. (1998). Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care, 21, 1414-1431.
3. Wen-Hang, Q. I. (2005). Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China. International Journal of Cardiology, 105, 283-287.
4. Movahed, M. R., Hashemzadeh, M., & Jamal, M. M. (2005). Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. International Journal of Cardiology, 105, 315-318.
5. Lip, G. Y., & Varughese, G. I. (2005). Diabetes mellitus and atrial fibrillation: Perspectives on epidemiological and pathophysiological links. International Journal of Cardiology, 105, 319-321.
6. Jeong, J. H. (2005). Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. Journal of Korean Medical Science, 20, 26-30.
7. Ostgren, C. J., Merlo, J., Rastam, L., & Lindblad, U. (2004). Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes, Obesity and Metabolism, 6, 367-374.
8. Psaty, B. M., Manolio, T. A., Kuller, L. H., Kronmal, R. A., Cushman, M., Fried, L. P., et al. (1997). Incidence of and risk factors for atrial fibrillation in older adults. Circulation, 96, 2455-2461.
9. Benjamin, E. J., Levy, D., Vaziri, S. M., D'Agostino, R. B., Belanger, A. J., Wolf, P. A. (1994). Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study. JAMA, 271, 840-844.
10. Pappone, C., Oreto, G., Lamberti, F., Vicedomini, G., Loricchio, M. L., Shpun, S., et al. (1999). Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation, 100, 1203-1208.
11. Goldberg, A., Menen, M., Mickelsen, S., MacIndoe, C., Binder, M., Nawman, R., et al. (2003). Atrial fibrillation ablation leads to long-term improvement of quality of life and reduced utilization of healthcare resources. Journal of Interventional Cardiac Electrophysiology, 8, 59-64.
12. Scholten, M. F., Thornton, A. S., Mekel, J. M., & Jordaens, L. J. (2006). Targets and endpoints in ablation therapy for atrial fibrillation in the light of pathophysiological mechanisms. Journal of Interventional Cardiac Electrophysiology, 15, 27-33.
13. Gurm, H. S., Sarembock, I. J., Kereiakes, D. J., Young, J. J., Harrington, R. A., Kleiman, N., et al. (2005). Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: An analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. Journal of the American College of Cardiology, 45, 1932-1938.
14. Prasad, A., Stone, G. W., Stuckey, T. D., Costantini, C. O., Zimetbaum, P. J., McLaughlin, M., et al. (2005). Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. Journal of the American College of Cardiology, 45, 508-514.
15. Flaherty, J. D., & Davidson, C. J. (2005). Diabetes and coronary revascularization. JAMA, 293, 1501-1508.
16. (1997). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183-1197.
17. Ouyang, F., Bansch, D., Ernst, S., Schaumann, A., Hachiya, H., Chen, M., et al. (2004). Complete isolation of left atrium surrounding the pulmonary veins: New insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation, 110, 2090-2096.
18. Lee, S. H., Tai, C. T., Hsieh, M. H., Tsai, C. F., Lin, Y. K., Tsao, H. M., et al. (2004). Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 10, 221-226.
19. Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998). Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. American Journal of Cardiology, 82, 2N-9N.
20. Kannel, W. B., Abbott, R. D., Savage, D. D., & McNamara, P. M. (1982). Epidemiologic features of chronic atrial fibrillation: The Framingham study. New England Journal of Medicine, 306, 1018-1022.
21. Yaras, N., & Turan, B. (2005). Interpretation of relevance of sodium-calcium exchange in action potential of diabetic rat heart by mathematical model. Molecular and Cellular Biochemistry, 269, 121-129.
22. Shimoni, Y., Hunt, D., Chuang, M., Chen, K. Y., Kargacin, G., & Severson, D. L. (2005). Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat. Journal of Physiology, 567, 177-190.
23. Kipshidze, N. N., Katsitadze, G. A., & Khosroshvili, L. B. (2005). Effect of the metabolic syndrome on the electrophysiological parameters of the heart. Georgian Med News, 119, 9-13.
24. Pandit, S. V., Giles, W. R., & Demir, S. S. (2003). A mathematical model of the electrophysiological alterations in rat ventricular myocytes in type-I diabetes. Biophysical Journal, 84, 832-841.
25. Glatter, K. A., & Chiamvimonvat, N. (2005). Autonomic nerve innervation and the left atrium: A mechanistic link to focal atrial fibrillation. Heart Rhythm, 2, 523-524.
26. Abraham, R. R., Abraham, R. M., & Wynn, V. (1986). Autonomic and electrophysiological studies in patients with signs or symptoms of diabetic neuropathy. Electroencephalography and Clinical Neurophysiology, 63, 223-230.
27. Potpara, T., Marinkovic-Eric, J., Grujic, M., Radojkovic-Cirovic, B., Vujisic-Tesic, B., & Petrovic, M. (2002). Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation. Srpski Arhiv Za Celokupno Lekarstvo, 130, 189-192.
28. Sugishita, K., Shiono, E., Sugiyama, T., & Ashida, T. (2003). Diabetes influences the cardiac symptoms related to atrial fibrillation. Circulation Journal, 67, 835-838.
29. Cappato, R., Calkins, H., Chen, S. A., Davies, W., Iesaka, Y., Kalman, J., et al. (2005). Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation, 111, 1100-1105.
30. DiMarco, J. P., Flaker, G., Waldo, A. L., Corley, S. D., Greene, H. L., Safford, R. E., et al. (2005). Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. American Heart Journal, 149, 650-656.
31. Schneider, D. J. (2005). Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance. Coronary Artery Disease, 16, 473-476.
32. Pappone, C., Rosanio, S., Augello, G., Gallus, G., Vicedomini, G., Mazzone, P., et al. (2003). Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. Journal of the American College of Cardiology, 42, 185-197.